Asia Pacific COPD and Asthma Devices Market
Degrading air quality near the industrial areas has led to the increased incidence of asthma especially in the low-income population in the emerging economies. Increasing disposable income levels in emerging economies as well as developing countries has led to the increased usage of asthma pumps and sprays in these regions.
Asia Pacific COPD and Asthma Devices Market Overview
Asia Pacific is expected to be the fastest regional market for asthma and COPD devices owing to the increased incidence of asthma & other respiratory diseases in industrial regions. The Asia Pacific market for Asthma & COPD has been analyzed on the basis of drugs and devices used for these diseases. Key drugs employed for control and diagnosis of asthma and COPD may be classified on the basis of their types which include bronchodilators, leukotriene antagonists, mast cell stabilizers and immunosuppressants. Degrading air quality near the industrial areas has led to the increased incidence of asthma especially in the low-income population in the emerging economies. Increasing disposable income levels in emerging economies as well as developing countries has led to the increased usage of asthma pumps and sprays in these regions.
Asia Pacific COPD and Asthma Devices Market Highlights
The report highlights the adoption of COPD & Asthma Devices in Asia Pacific. Based on the product type; the market is segmented into Inhalers and Nebulizers market. Further the Inhaler segment is sub segmented into Dry Powder Inhalers, Metered Dose Inhalers and Soft Mist Inhalers Market. The Nebulizers segment is bifurcated into Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers Market. The countries included in the report are Germany, UK, France, Russia, Spain, Italy and Rest of Asia Pacific.
Asia Pacific COPD and Asthma Devices Market Key Companies
Key players profiled in the report include Glaxosmithcline PLC., Novartis International AG., Biotronik SE & Co. KG., AstraZeneca Plc., 3M Healthcare, GF Health Products, Inc., Sunovion Pharmaceuticals Inc., Smith Medicals, Inc., Baxter International and Philips.
Asia Pacific COPD and Asthma Devices Market Segmentation
Asia Pacific COPD & Asthma Devices, By Product Type
- Asia Pacific COPD & Asthma Devices Market
- Asia Pacific COPD & Asthma Inhaler Market
- Asia Pacific COPD & Asthma Dry Powder Inhalers (DPIs) Market
- Asia Pacific COPD & Asthma Metered Dose Inhalers (MDIs) Market
- Asia Pacific COPD & Asthma Soft Mist Inhalers (SMIs) Market
- Asia Pacific COPD & Asthma Nebulizer Market
- Asia Pacific COPD & Asthma Pneumatic Nebulizers Market
- Asia Pacific COPD & Asthma Ultrasonic Nebulizer Market
- Asia Pacific COPD & Asthma Mesh Nebulizer Market
- Asia Pacific COPD & Asthma Inhaler Market
Asia Pacific COPD & Asthma Devices Market, By Country
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Malaysia
- Rest of Asia Pacific
Unique Offerings from KBV Research
- Exhaustive coverage of Asia Pacific COPD and Asthma Devices Market
- Highest number of market tables (1079 Tables, 573 Pages)
- Unique “Market Research & Analytics Tool” to provide instant comparative analysis within the report
- Subscription based model available
- Free of cost quarterly updates
- Free of cost automatic pdf report generation
- Guaranteed best price
- Assured post sales research support with 10% customization free
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 MARKET SCOPE
1.4 SEGMENTATION
1.4.1 Asia Pacific COPD & Asthma Devices, By Product Type
1.4.2 Asia Pacific COPD & Asthma Devices Market, By Country
1.5 Research Methodology
Chapter 2. Asia Pacific COPD and Asthma Devices Market Overview
2.1 Introduction
2.2 Key Influencing Factors
2.3 Asia Pacific COPD & Asthma Device Market
Chapter 3. Asia Pacific COPD and Asthma Device Market – By Product Type
3.1 Asia Pacific COPD & Asthma Inhaler Market
3.1.1 Asia Pacific COPD & Asthma Inhaler Market – By Product Type
3.1.1.1.1 Asia Pacific COPD & Asthma Dry Powder Inhalers (DPIs) Market
3.1.1.1.2 Asia Pacific COPD & Asthma Metered Dose Inhalers (MDIs) Market
3.1.1.1.3 Asia Pacific COPD & Asthma Soft Mist Inhalers (SMIs) Market
3.1.1.2 Asia Pacific COPD & Asthma Inhaler Market
3.1.1.2.1 Asia Pacific COPD & Asthma Inhaler Market – By Country
3.1.1.2.2 Asia Pacific COPD & Asthma Dry Powder Inhalers (DPIs) Market
3.1.1.2.3 Asia Pacific COPD & Asthma Metered Dose Inhalers (MDIs) Market
3.1.1.2.4 Asia Pacific COPD & Asthma Soft Mist Inhalers (SMIs) Market
3.1.1.2.5 Asia Pacific COPD & Asthma Pneumatic Nebulizer Market
3.1.1.2.6 Asia Pacific COPD & Asthma Ultrasonic Nebulizer Market – By Country
3.1.1.2.7 Asia Pacific COPD & Asthma Mesh Nebulizer Market – By Country
3.1.1.3 Asia Pacific COPD & Asthma Nebulizer Market – By Product Type
3.1.1.3.1 Asia Pacific COPD & Asthma Nebulizer Market – By Country
3.1.1.3.2 Asia Pacific COPD & Asthma Pneumatic Nebulizer Market
3.1.1.3.3 Asia Pacific COPD & Asthma Ultrasonic Nebulizer Market
3.1.1.3.4 Asia Pacific COPD & Asthma Mesh Nebulizer Market
Chapter 4. Asia Pacific COPD & Asthma Devices Market – By Country
4.1 Asia Pacific COPD & Asthma Device Market
4.1.1 China COPD and Asthma Devices Market
4.1.1.1 China COPD and Asthma Devices Market – By Product Type
4.1.1.1.1 China COPD and Asthma Inhalers Market
4.1.1.1.2 China COPD and Asthma Nebulizers Market
4.1.2 Japan COPD and Asthma Devices Market
4.1.2.1 Japan COPD and Asthma Devices Market – By Product Type
4.1.2.1.1 Japan COPD and Asthma Inhalers Market
4.1.2.1.2 Japan COPD and Asthma Nebulizers Market
4.1.3 India COPD and Asthma Devices Market
4.1.3.1 India COPD and Asthma Inhalers Market – By Product Type
4.1.3.1.1 India COPD and Asthma Inhalers Market
4.1.3.1.2 India COPD and Asthma Nebulizers Market
4.1.4 South Korea COPD and Asthma Devices Market
4.1.4.1 South Korea COPD and Asthma Devices Market – By Product Type
4.1.4.1.1 South Korea COPD and Asthma Inhalers Market
4.1.4.1.2 South Korea COPD and Asthma Nebulizers Market
4.1.5 Australia COPD and Asthma Devices Market
4.1.5.1 Australia COPD and Asthma Devices Market – By Product Type
4.1.5.1.1 Australia COPD and Asthma Inhalers Market
4.1.5.1.2 Australia COPD and Asthma Nebulizers Market
4.1.6 Malaysia COPD and Asthma Devices Market
4.1.6.1 Malaysia COPD and Asthma Devices Market – By Product Type
4.1.6.1.1 Malaysia COPD and Asthma Inhalers Market
4.1.6.1.2 Malaysia COPD and Asthma Nebulizers Market
4.1.7 Rest of Asia Pacific COPD and Asthma Devices Market
4.1.7.1 Rest of Asia Pacific COPD and Asthma Devices Market – By Product Type
4.1.7.1.1 Rest of Asia Pacific COPD and Asthma Inhalers Market
4.1.7.1.2 Rest of Asia Pacific COPD and Asthma Nebulizers Market
Chapter 5. Company Profiles
5.1 Glaxosmithcline PLC
5.1.1 Company Overview
5.1.2 Financial Analysis
5.1.3 Segmental Analysis
5.1.4 Research & Development
5.2 Novartis International AG
5.2.1 Company Overview
5.2.2 Financial Analysis
5.2.3 Segmental Analysis
5.2.4 Research & Development
5.3 Merck & Co., Inc.
5.3.1 Company Overview
5.3.2 Financial Analysis
5.3.3 Segmental Analysis
5.3.4 Research & Development
5.4 AstraZeneca Plc
5.4.1 Company Overview
5.4.2 Financial Analysis
5.4.3 Segmental Analysis
5.4.4 Research & Development
5.5 3M Healthcare
5.5.1 Company Overview
5.5.2 Financial Analysis
5.5.3 Segmental Analysis
5.5.4 Research & Development
5.6 GF Health Products, Inc
5.6.1 Company Overview
5.7 Sunovion Pharmaceuticals Inc.
5.7.1 Company Overview
5.8 Smith Medicals, Inc.
5.8.1 Company Overview
5.8.2 Financial Analysis
5.8.3 Segmental Analysis
5.9 Baxter International
5.9.1 Company Overview
5.9.2 Financial Analysis
5.9.3 Segmental Analysis
5.9.4 Research & Development
5.1 Koninklijke Philips N.V.
5.10.1 Company Overview
5.10.2 Financial Analysis
5.10.3 Segmental Analysis
5.10.4 Research & Development
List of Tables
TABLE 1 ASIA PACIFIC COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 2 ASIA PACIFIC COPD & ASTHMA DEVICE MARKET ($ MILLION): 2016-2022
TABLE 3 ASIA PACIFIC COPD & ASTHMA DEVICE MARKET, BY COUNTRY ($ MILLION): 2012-2015
TABLE 4 ASIA PACIFIC COPD & ASTHMA DEVICE MARKET, BY COUNTRY ($ MILLION): 2016-2022
TABLE 5 ASIA PACIFIC COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 6 ASIA PACIFIC COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 7 ASIA PACIFIC COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 8 ASIA PACIFIC COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 9 ASIA PACIFIC COPD AND ASTHMA DRY POWDER INHALERS (DPIS) MARKET ($ MILLION): 2012-2015
TABLE 10 ASIA PACIFIC COPD AND ASTHMA DRY POWDER INHALERS (DPIS) MARKET ($ MILLION): 2016-2022
TABLE 11 ASIA PACIFIC COPD AND ASTHMA METERED DOSE INHALERS (MDIS) MARKET – BY COUNTRY ($ MILLION): 2012-2015
TABLE 12 ASIA PACIFIC COPD AND ASTHMA METERED DOSE INHALERS (MDIS) MARKET – BY COUNTRY ($ MILLION): 2016-2022
TABLE 13 ASIA PACIFIC COPD AND ASTHMA SOFT MIST INHALERS (SMIS) MARKET – BY COUNTRY ($ MILLION): 2012-2015
TABLE 14 ASIA PACIFIC COPD AND ASTHMA SOFT MIST INHALERS (SMIS) MARKET – BY COUNTRY ($ MILLION): 2016-2022
TABLE 15 ASIA PACIFIC COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 16 ASIA PACIFIC COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 17 ASIA PACIFIC COPD AND ASTHMA INHALERS MARKET, BY COUNTRY ($ MILLION): 2012-2015
TABLE 18 ASIA PACIFIC COPD AND ASTHMA INHALERS MARKET, BY COUNTRY ($ MILLION): 2016-2022
TABLE 19 ASIA PACIFIC COPD AND ASTHMA DRY POWDER INHALERS (DPIS) MARKET ($ MILLION): 2012-2015
TABLE 20 ASIA PACIFIC COPD AND ASTHMA DRY POWDER INHALERS (DPIS) MARKET ($ MILLION): 2016-2022
TABLE 21 ASIA PACIFIC COPD AND ASTHMA METERED DOSE INHALERS (MDIS) MARKET – BY COUNTRY ($ MILLION): 2012-2015
TABLE 22 ASIA PACIFIC COPD AND ASTHMA METERED DOSE INHALERS (MDIS) MARKET – BY COUNTRY ($ MILLION): 2016-2022
TABLE 23 ASIA PACIFIC COPD AND ASTHMA SOFT MIST INHALERS (SMIS) MARKET – BY COUNTRY ($ MILLION): 2012-2015
TABLE 24 ASIA PACIFIC COPD AND ASTHMA METERED DOSE INHALERS (MDIS) MARKET – BY COUNTRY ($ MILLION): 2016-2022
TABLE 25 ASIA PACIFIC COPD AND ASTHMA PNEUMATIC NEBULIZER MARKET – BY COUNTRY ($ MILLION): 2012-2015
TABLE 26 ASIA PACIFIC COPD AND ASTHMA METERED DOSE INHALERS (MDIS) MARKET – BY COUNTRY ($ MILLION): 2016-2022
TABLE 27 ASIA PACIFIC COPD AND ASTHMA ULTRASONIC NEBULIZER MARKET – BY COUNTRY ($ MILLION): 2012-2015
TABLE 28 ASIA PACIFIC COPD AND ASTHMA ULTRASONIC NEBULIZER MARKET – BY COUNTRY ($ MILLION): 2016-2022
TABLE 29 ASIA PACIFIC COPD AND ASTHMA MESH NEBULIZER MARKET – BY COUNTRY ($ MILLION): 2012-2015
TABLE 30 ASIA PACIFIC COPD AND ASTHMA MESH NEBULIZER MARKET – BY COUNTRY ($ MILLION): 2016-2022
TABLE 31 ASIA PACIFIC COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 32 ASIA PACIFIC COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 33 ASIA PACIFIC COPD AND ASTHMA NEBULIZERS MARKET, BY COUNTRY ($ MILLION): 2012-2015
TABLE 34 ASIA PACIFIC COPD AND ASTHMA NEBULIZERS MARKET, BY COUNTRY ($ MILLION): 2016-2022
TABLE 35 ASIA PACIFIC COPD AND ASTHMA PNEUMATIC NEBULIZER MARKET – BY COUNTRY ($ MILLION): 2012-2015
TABLE 36 ASIA PACIFIC COPD AND ASTHMA PNEUMATIC NEBULIZER MARKET – BY COUNTRY ($ MILLION): 2016-2022
TABLE 37 ASIA PACIFIC COPD AND ASTHMA ULTRASONIC NEBULIZER MARKET – BY COUNTRY ($ MILLION): 2012-2015
TABLE 38 ASIA PACIFIC COPD AND ASTHMA ULTRASONIC NEBULIZER MARKET – BY COUNTRY ($ MILLION): 2016-2022
TABLE 39 ASIA PACIFIC COPD AND ASTHMA MESH NEBULIZER MARKET – BY COUNTRY ($ MILLION): 2012-2015
TABLE 40 ASIA PACIFIC COPD AND ASTHMA MESH NEBULIZER MARKET – BY COUNTRY ($ MILLION): 2016-2022
TABLE 41 ASIA PACIFIC COPD & ASTHMA DEVICE MARKET, BY COUNTRY ($ MILLION): 2012-2015
TABLE 42 ASIA PACIFIC COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY ($ MILLION): 2016-2022
TABLE 43 CHINA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 44 CHINA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2016-2022
TABLE 45 CHINA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 46 CHINA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 47 CHINA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 48 CHINA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 49 CHINA COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 50 CHINA COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 51 JAPAN COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 52 JAPAN COPD & ASTHMA DEVICE MARKET ($ MILLION): 2016-2022
TABLE 53 JAPAN COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 54 JAPAN COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 55 JAPAN COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 56 JAPAN COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 57 JAPAN COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 58 JAPAN COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 59 INDIA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 60 INDIA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2016-2022
TABLE 61 INDIA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 62 INDIA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 63 INDIA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 64 INDIA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 65 INDIA COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 66 INDIA COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 67 SOUTH KOREA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 68 SOUTH KOREA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2016-2022
TABLE 69 SOUTH KOREA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 70 SOUTH KOREA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 71 SOUTH KOREA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 72 SOUTH KOREA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 73 SOUTH KOREA COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2012-2015
TABLE 74 SOUTH KOREA COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2016-2022
TABLE 75 AUSTRALIA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 76 AUSTRALIA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2016-2022
TABLE 77 AUSTRALIA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 78 AUSTRALIA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 79 AUSTRALIA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 80 AUSTRALIA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 81 AUSTRALIA COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 82 AUSTRALIA COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 83 MALAYSIA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 84 MALAYSIA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2016-2022
TABLE 85 MALAYSIA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 86 MALAYSIA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 87 MALAYSIA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 88 MALAYSIA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 89 MALAYSIA COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 90 MALAYSIA COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 91 REST OF ASIA PACIFIC COPD & ASTHMA DEVICE MARKET – BY COUNTRY ($ MILLION): 2012-2015
TABLE 92 REST OF ASIA PACIFIC COPD & ASTHMA DEVICE MARKET – BY COUNTRY ($ MILLION): 2016-2022
TABLE 93 REST OF ASIA PACIFIC COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 94 REST OF ASIA PACIFIC COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 95 REST OF ASIA PACIFIC COPD AND ASTHMA INHALERS MARKET – BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 96 REST OF ASIA PACIFIC COPD AND ASTHMA INHALERS MARKET – BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 97 REST OF ASIA PACIFIC COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 98 REST OF ASIA PACIFIC COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 99 KEY INFORMATION – GLAXOSMITHCLINE PLC.
TABLE 100 KEY INFORMATION – NOVARTIS INTERNATIONAL AG.
TABLE 101 KEY INFORMATION – BIOTRONIK SE & CO. KG.
TABLE 102 KEY INFORMATION – ASTRAZENECA PLC.
TABLE 103 KEY INFORMATION – 3M HEALTHCARE.
TABLE 104 KEY INFORMATION – GF HEALTH PRODUCTS, INC.
TABLE 105 KEY INFORMATION – SUNOVION PHARMACEUTICALS INC.
TABLE 106 KEY INFORMATION – SMITH MEDICALS, INC.
TABLE 107 KEY INFORMATION – BAXTER INTERNATIONAL.
TABLE 108 KONINKLIJKE PHILIPS N.V. COMPANY SNAPSHOT
